These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 39091353)

  • 1. Implications of anemia in patients undergoing PCI with Impella-support: insights from the PROTECT III study.
    Falah B; Redfors B; Zhao D; Bharadwaj AS; Basir MB; Thompson JB; Patel RAG; Schonning MJ; Abu-Much A; Zhang Y; Batchelor WB; Grines CL; O'Neill WW
    Front Cardiovasc Med; 2024; 11():1429900. PubMed ID: 39091353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes among patients with mitral valve regurgitation undergoing Impella-supported high-risk PCI.
    Abu-Much A; Grines CL; Chen S; Batchelor WB; Zhao D; Falah B; Maini AS; Redfors B; Bellumkonda L; Bharadwaj AS; Moses JW; Truesdell AG; Zhang Y; Zhou Z; Baron SJ; Lansky AJ; Basir MB; O'Neill WW; Cohen DJ
    Int J Cardiol; 2024 Dec; 417():132555. PubMed ID: 39270940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex Differences in pLVAD-Assisted High-Risk Percutaneous Coronary Intervention: Insights From the PROTECT III Study.
    Shah T; Abu-Much A; Batchelor WB; Grines CL; Baron SJ; Zhou Z; Li Y; Maini AS; Redfors B; Hussain Y; Wollmuth JR; Basir MB; O'Neill WW; Lansky AJ
    JACC Cardiovasc Interv; 2023 Jul; 16(14):1721-1729. PubMed ID: 37409991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiographic Characteristics and Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study.
    Bharadwaj AS; Abu-Much A; Maini AS; Zhou Z; Li Y; Batchelor WB; Grines CL; Baron SJ; Redfors B; Lansky AJ; Basir MB; O'Neill WW
    Circ Cardiovasc Interv; 2024 Jul; 17(7):e013503. PubMed ID: 38708609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right Ventricular Dysfunction in Patients Undergoing High-Risk PCI with Impella.
    Rommel KP; Bonnet G; Bellumkonda L; Lansky AJ; Zhao D; Thompson JB; Zhang Y; Redfors B; Lurz PC; Granada JF; Bharadwaj AS; Basir MB; O'Neill WW; Burkhoff D
    J Card Fail; 2024 Oct; 30(10):1244-1254. PubMed ID: 39389734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of left ventricular ejection fraction in patients undergoing contemporary pLVAD-supported high-risk PCI.
    Abu-Much A; Grines CL; Batchelor WB; Maini AS; Zhang Y; Redfors B; Bellumkonda L; Bharadwaj AS; Moses JW; Truesdell AG; Li Y; Baron SJ; Lansky AJ; Basir MB; Cohen DJ; O'Neill WW
    Am Heart J; 2024 Mar; 269():139-148. PubMed ID: 38151142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Preprocedural SYNTAX Score With Outcomes in Impella-Assisted High-Risk Percutaneous Coronary Intervention.
    Medranda GA; Faraz HA; Thompson JB; Zhang Y; Bharadwaj AS; Osborn EA; Abu-Much A; Lansky AJ; Basir MB; Moses JW; O'Neill WW; Grines CL; Baron SJ
    J Soc Cardiovasc Angiogr Interv; 2024 Aug; 3(8):101981. PubMed ID: 39166169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved outcomes in patients with severely depressed LVEF undergoing percutaneous coronary intervention with contemporary practices.
    O'Neill WW; Anderson M; Burkhoff D; Grines CL; Kapur NK; Lansky AJ; Mannino S; McCabe JM; Alaswad K; Daggubati R; Wohns D; Meraj PM; Pinto DS; Popma JJ; Moses JW; Schreiber TL; Magnus Ohman E
    Am Heart J; 2022 Jun; 248():139-149. PubMed ID: 35192839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in left ventricular function and outcomes following high-risk percutaneous coronary intervention with Impella-guided hemodynamic support.
    Farhan S; Freilich M; Giustino G; Vogel B; Baber U; Sartori S; Kamran H; Mehran R; Dangas G; Krishnan P; Kini A; Sharma SK
    Front Cardiovasc Med; 2024; 11():1416613. PubMed ID: 39036507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous coronary intervention with Impella support with and without intra-aortic balloon in cardiogenic shock patients.
    Bhuiyan R; Bimal T; Fishbein J; Gandotra P; Selim S; Ong L; Gruberg L
    Cardiovasc Revasc Med; 2023 Oct; 55():68-73. PubMed ID: 37076412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial).
    Dangas GD; Kini AS; Sharma SK; Henriques JP; Claessen BE; Dixon SR; Massaro JM; Palacios I; Popma JJ; Ohman M; Stone GW; O'Neill WW
    Am J Cardiol; 2014 Jan; 113(2):222-8. PubMed ID: 24527505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of anemic patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Abe K; Kitahara H; Suzuki S; Hiraga T; Yamazaki T; Ohno Y; Harada J; Fukushima K; Asano T; Ishio N; Uchiyama R; Miyahara H; Okino S; Sano M; Kuriyama N; Yamamoto M; Sakamoto N; Kanda J; Kobayashi Y
    Int J Cardiol; 2024 Jun; 405():131989. PubMed ID: 38521510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonemergent Percutaneous Coronary Intervention on an Unprotected Left Main Coronary Artery Supported with Impella® Heart Pump in Patients Ineligible for Surgical Revascularization.
    Meraj PM; Dixon S; Moses J; Ibrahim K; Schäfer A; Akin I; Hill J; Schreiber T; O'Neill WW
    J Interv Cardiol; 2019; 2019():9691753. PubMed ID: 31772553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleeding and Subsequent Cardiovascular Events and Death in Atrial Fibrillation With Stable Coronary Artery Disease: Insights From the AFIRE Trial.
    Kaikita K; Yasuda S; Akao M; Ako J; Matoba T; Nakamura M; Miyauchi K; Hagiwara N; Kimura K; Hirayama A; Matsui K; Ogawa H
    Circ Cardiovasc Interv; 2021 Nov; 14(11):e010476. PubMed ID: 34474583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention.
    Faggioni M; Baber U; Sartori S; Chandrasekhar J; Cohen DJ; Henry TD; Claessen BE; Dangas GD; Gibson CM; Krucoff MW; Vogel B; Moliterno DJ; Sorrentino S; Colombo A; Chieffo A; Kini A; Farhan S; Ariti C; Witzenbichler B; Weisz G; Steg PG; Pocock S; Mehran R
    Circ Cardiovasc Interv; 2019 Apr; 12(4):e007133. PubMed ID: 30998384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification algorithm for clinical outcomes in anemic patients undergoing percutaneous coronary intervention.
    Ke B; Gong R; Shen A; Qiu H; Chen H; Zhang Z; Li W; Xie Y; Li H
    Ann Med; 2023; 55(2):2249200. PubMed ID: 37619547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Impact of Baseline Hemoglobin Levels on Long-Term Thrombotic and Bleeding Events After Percutaneous Coronary Interventions.
    Nagao K; Watanabe H; Morimoto T; Inada T; Hayashi F; Nakagawa Y; Furukawa Y; Kadota K; Akasaka T; Natsuaki M; Kozuma K; Tanabe K; Morino Y; Shiomi H; Kimura T;
    J Am Heart Assoc; 2019 Nov; 8(22):e013703. PubMed ID: 31701786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?
    Syed AI; Kakkar A; Torguson R; Li Y; Ben-Dor I; Collins SD; Lemesle G; Maluenda G; Xue Z; Scheinowitz M; Kaneshige K; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Cardiovasc Revasc Med; 2010; 11(2):91-7. PubMed ID: 20347798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention.
    O'Neill BP; Grines C; Moses JW; Ohman EM; Lansky A; Popma J; Kapur NK; Schreiber T; Mannino S; O'Neill WW; Medjamia AM; Mahmud E
    Catheter Cardiovasc Interv; 2021 Oct; 98(4):E501-E512. PubMed ID: 34051033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Impella-supported high-risk nonemergent percutaneous coronary intervention in a large single-center registry.
    Azzalini L; Johal GS; Baber U; Bander J; Moreno PR; Bazi L; Kapur V; Barman N; Kini AS; Sharma SK
    Catheter Cardiovasc Interv; 2021 Jan; 97(1):E26-E33. PubMed ID: 32333721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.